Literature DB >> 29880119

Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.

Jorge A Wong1, David Conen2, Isabelle C Van Gelder3, William F McIntyre2, Harry J Crijns4, Jia Wang2, Michael R Gold5, Stefan H Hohnloser6, C P Lau7, Alessandro Capucci8, Gianluca Botto9, Gerian Grönefeld10, Carsten W Israel5, Stuart J Connolly2, Jeff S Healey2.   

Abstract

BACKGROUND: Long-term continuous monitoring detects short-lasting, subclinical atrial fibrillation (SCAF) in approximately one-third of older individuals with cardiovascular conditions. The relationship between SCAF, its progression, and the development of heart failure (HF) is unclear.
OBJECTIVES: This study examined the relationship between progression from shorter to longer SCAF episodes and HF hospitalization.
METHODS: Subjects in ASSERT (Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial) were ≥65 years old, had history of hypertension, no prior clinical AF, and an implanted pacemaker or defibrillator. We examined patients whose longest SCAF episode during the first year after enrollment was >6 min but ≤24 h (n = 415). Using time-dependent Cox models, we evaluated the relationship between subsequent development of SCAF >24 h or clinical AF and HF hospitalization.
RESULTS: Over a mean follow-up of 2 years, 65 patients (15.7%) progressed to having SCAF episodes >24 h or clinical AF (incidence 8.8% per year). Older age, greater body mass index, and longer SCAF duration within the first year were independent predictors of SCAF progression. The rate of HF hospitalization among patients with SCAF progression was 8.9% per year compared with 2.5% per year for those without progression. After multivariable adjustment, SCAF progression was independently associated with HF hospitalization (hazard ratio [HR]: 4.58; 95% confidence interval [CI]: 1.64 to 12.80; p = 0.004). Similar results were observed when we excluded patients with prior history of HF (HR: 7.06; 95% CI: 1.82 to 27.30; p = 0.005) or when SCAF progression was defined as development of SCAF >24 h alone (HR: 3.68; 95% CI: 1.27 to 10.70; p = 0.016).
CONCLUSIONS: In patients with a pacemaker or defibrillator, SCAF progression was strongly associated with HF hospitalization.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; atrial fibrillation progression; health outcome; heart failure; predictors; subclinical atrial fibrillation

Mesh:

Year:  2018        PMID: 29880119     DOI: 10.1016/j.jacc.2018.03.519

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

1.  2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yu-Feng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-12

2.  2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yufeng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Cardiovasc Digit Health J       Date:  2021-01-29

3.  Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator.

Authors:  Jie Chen; Peng Yu; Jianyong Ma; Chunhua Zheng; Xiao Liu
Journal:  Clin Cardiol       Date:  2021-01-19       Impact factor: 2.882

4.  Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the UK.

Authors:  Claudia I Rinciog; Laura M Sawyer; Alexander Diamantopoulos; Mitchell S V Elkind; Matthew Reynolds; Stylianos I Tsintzos; Paul D Ziegler; Maria E Quiroz; Claudia Wolff; Klaus K Witte
Journal:  Open Heart       Date:  2019-06-20

5.  Reactive atrial-based antitachycardia pacing therapy reduces atrial tachyarrhythmias.

Authors:  George H Crossley; Luigi Padeletti; Steven Zweibel; J Harrison Hudnall; Yan Zhang; Giuseppe Boriani
Journal:  Pacing Clin Electrophysiol       Date:  2019-04-29       Impact factor: 1.976

6.  Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V.

Authors:  Ruben R De With; Ömer Erküner; Michiel Rienstra; Bao-Oanh Nguyen; Frank W J Körver; Dominik Linz; Hugo Cate Ten; Henri Spronk; Abraham A Kroon; Alexander H Maass; Yuri Blaauw; Robert G Tieleman; Martin E W Hemels; Joris R de Groot; Arif Elvan; Mirko de Melis; Coert O S Scheerder; Meelad I H Al-Jazairi; Ulrich Schotten; Justin G L M Luermans; Harry J G M Crijns; Isabelle C Van Gelder
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

7.  Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure.

Authors:  Jiachen Luo; Siling Xu; Hongqiang Li; Zhiqiang Li; Baoxin Liu; Xiaoming Qin; Mengmeng Gong; Beibei Shi; Yidong Wei
Journal:  ESC Heart Fail       Date:  2020-06-23

8.  Editorial to "Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation".

Authors:  Chu-Pak Lau; Kathy Lai-Fun Lee; Chung-Wah Siu; Hung-Fat Tse
Journal:  J Arrhythm       Date:  2020-12-21

Review 9.  Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.

Authors:  Ahmed AlTurki; Mariam Marafi; Vincenzo Russo; Riccardo Proietti; Vidal Essebag
Journal:  Medicina (Kaunas)       Date:  2019-09-20       Impact factor: 2.430

Review 10.  Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop.

Authors:  Sana M Al-Khatib; Emelia J Benjamin; Christine M Albert; Alvaro Alonso; Cynthia Chauhan; Peng-Sheng Chen; Anne B Curtis; Patrice Desvigne-Nickens; Jennifer E Ho; Carolyn S P Lam; Mark S Link; Kristen K Patton; Margaret M Redfield; Michiel Rienstra; Yves Rosenberg; Renate Schnabel; John A Spertus; Lynne Warner Stevenson; Mellanie True Hills; Adriaan A Voors; Lawton S Cooper; Alan S Go
Journal:  Circulation       Date:  2020-06-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.